Nasdaq: DMRA
Damora Therapeutics insiders
The officers, directors and 10% owners of Damora Therapeutics, Inc. who hold the most stock, valued at the live DMRA price.
$24.30
DMRA today +$1.3M (+5.74%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their DMRA stock
- $18.9M
- Market value
- $1.50B
- Held by ranked insiders
- 1.26%
Insiders by value of DMRA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jennifer Jarrett | Director, President and CEO | 512,500 | $12.5M | 0.83% | 5980th |
| 2 | L. Becker Hewes | Chief Medical Officer | 264,629 | $6.4M | 0.43% | 12131st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Damora Therapeutics; see each profile for the filing.